-
Our Experts
David M. Oakley, R.Ph., Ph.D.
Director of Technical Development
AAI PharmaDavid M. Oakley, R.Ph., Ph.D., Director of Technical Development AAIPharma Services Corp, Wilmington, NC Dr. Oakley received his BS in Pharmacy and a Ph.D. degree in Pharmaceutics from the University of North Carolina. Dr. Oakley has 23 years of development experience in drug delivery technology, solid oral, nasal, and topical drug products and has authored or co-authored 22 research articles and abstracts. AAIPharma Services provides product development services to pharmaceutical and biotechnology companies. Our pharmaceutical professionals provide solutions to difficult drug development challenges. We have supported over 500 IND’s, and 50 NDA’s/ANDA’s. Our services include analytical/formulation, clinical packaging, manufacturing, oral drug delivery technologies, and complete development packages to meet our customer’s needs. 
Graham Wood, PhD
President, Clinical Operations
Cetero Research Clinical Operations ServicesGraham Wood is President of Cetero Research Clinical Operations Services in Toronto, Canada and Miami, FL. He has more than 12 years of experience in contract research with a background in clinical pharmacology operations, business development and project management.
Dr. Wood manages the operation of two clinical pharmacology facilities that consist of 213 beds, seven Environmental Exposure Chambers (EEC), clinical trial management, clinical monitoring and scientific affairs.
Dr. Wood has a PhD in Neurology and Neurosurgery from McGill University, Montreal, Quebec, Canada, and Hon. BSc degree in Biochemistry at McMaster University, Hamilton, Ontario, Canada. He has co-authored several publications presentations.
Richard Walovitch, Ph.D.
Chief Medical Officer
WorldCare ClinicalDr. Walovitch is chief medical officer of WorldCare Clinical. Prior to joining WCC, he served as the senior vice president of clinical research at Acusphere, Inc., vice president of preclinical and clinical research at Epix Medical, and research pharmacologist and project clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. Walovitch has a doctorate in pharmacology from the University of Illinois Medical Center and a bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.